Who invested in Emboline

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BeautyBiotechHealthcare

Raised 8 months ago

Funding summaryUpdated 26 Oct 2026

$30Mraised across 2 rounds since 2018, from 2 sources

$10MSeries B$20MVenture

Latest round: Venture, $20MMar 2026
Step-upi: 2×
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20182020202220242026

$10MSeries B$20MVenture

First round: Series B, $10M
Biggest round: $20M
Between rounds: 7.8 years

The rounds

Mar 2026
Venture$20M1 new
- Trinity Capital
Source recorded
Apr 2018
Series B$10M2 new
- ShangBay Capital
- SV Tech Ventures
Reported by FinSMEs

Founders and team

From Emboline's own website: 7 on the team.

Eric StorneVice President, Marketing and Clinical Relations
Josh ThielenVice President, Sales
Laura BrentonSenior Vice President, Clinical and Medical Affairs
Matt DavisVice President, Product Development
Stephen KleshinskiSenior Vice President, Research
Will MichulVice President, Quality and Regulatory Affairs
Mark CairesChief Financial Officer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2018Venture2026Trinity Capital

ShangBay Capital

SV Tech Ventures

Everyone who backed them

Trinity CapitalVC firm1round

ShangBay CapitalVC firm1round

SV Tech VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Emboline as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.